27-Hydroxycholesterol induces macrophage gene expression via LXR-dependent and -independent mechanisms

27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a pote...

Full description

Saved in:
Bibliographic Details
Published inThe Korean journal of physiology & pharmacology Vol. 25; no. 2; pp. 111 - 118
Main Authors Kim, Bo-Young, Son, Yonghae, Cho, Hyok-rae, Lee, Dongjun, Eo, Seong-Kug, Kim, Koanhoi
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Physiological Society and The Korean Society of Pharmacology 01.03.2021
대한약리학회
Subjects
Online AccessGet full text
ISSN1226-4512
2093-3827
DOI10.4196/kjpp.2021.25.2.111

Cover

Abstract 27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterolinduced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms.
AbstractList 27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterol-induced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms.
27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterolinduced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms.27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterolinduced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms.
27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterolinduced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms KCI Citation Count: 0
27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene expression, we investigated the effects of LXR inhibition on the 27OHChol-induced genes. Treatment of human THP-1 cells with GSK 2033, a potent cell-active LXR antagonist, results in complete inhibition in the transcription of LXR target genes (such as LXRα and ABCA1) induced by 27OHChol or a synthetic LXR ligand TO 901317. Whereas expression of CCL2 and CCL4 remains unaffected by GSK 2033, TNF-α expression is further induced and 27OHChol-induced CCL3 and CXCL8 genes are suppressed at both the transcriptional and protein translation levels in the presence of GSK 2033. This LXR antagonist downregulates transcript levels and surface expression of CD163 and CD206 and suppresses the transcription of CD14, CD80, and CD86 genes without downregulating their surface levels. GSK 2033 alone had no effect on the basal expression levels of the aforementioned genes. Collectively, these results indicate that LXR inhibition leads to differential regulation of 27-hydroxycholesterolinduced genes in macrophages. We propose that 27OHChol induces gene expression and modulates macrophage functions via LXR-dependent and -independent mechanisms.
Author Kim, Koanhoi
Kim, Bo-Young
Cho, Hyok-rae
Son, Yonghae
Eo, Seong-Kug
Lee, Dongjun
AuthorAffiliation 2 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
1 Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Korea
3 Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Korea
4 College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan 54596, Korea
AuthorAffiliation_xml – name: 3 Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Korea
– name: 1 Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Korea
– name: 2 Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
– name: 4 College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan 54596, Korea
Author_xml – sequence: 1
  givenname: Bo-Young
  surname: Kim
  fullname: Kim, Bo-Young
  organization: Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Korea
– sequence: 2
  givenname: Yonghae
  surname: Son
  fullname: Son, Yonghae
  organization: Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Korea
– sequence: 3
  givenname: Hyok-rae
  surname: Cho
  fullname: Cho, Hyok-rae
  organization: Department of Neurosurgery, Kosin University College of Medicine, Busan 49267, Korea
– sequence: 4
  givenname: Dongjun
  surname: Lee
  fullname: Lee, Dongjun
  organization: Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Korea
– sequence: 5
  givenname: Seong-Kug
  surname: Eo
  fullname: Eo, Seong-Kug
  organization: College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan 54596, Korea
– sequence: 6
  givenname: Koanhoi
  surname: Kim
  fullname: Kim, Koanhoi
  organization: Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33602881$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002689670$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9Uctu1DAUtVARHUp_gAXKEhYJfiWxN0hVVWilkZCqIrGzHOd6xkxiBztTdf4eT6eMShesrmSf173nLTrxwQNC7wmuOJHN582vaaoopqSidUUrQsgrtKBYspIJ2p6gBaG0KXlN6Ck6T8l1GIsa1wLLN-iUsQZTIcgCWdqW17s-hoedWYcB0gwxDIXz_dZAKkZtYpjWegXFCjwU8DBFyGrBF_dOF8uft2UPE_ge_Fxo3xdlZh4fRjBr7V0a0zv02uohwfnTPEM_vl7dXV6Xy-_fbi4vlqXhrJlLLjouczTW2JZy2XPMBJMaNABvaFNbifsOrIWWso5zMKTVTdeSurMaa-DsDH066Ppo1cY4FbR7nKugNlFd3N7dKNnWjBGasV8O2GnbjdCbnDjqQU3RjTruHpn__ni3zjr3qhWScbk3-_gkEMPvbT6dGl0yMAzaQ9gmlTcgkuNasgz98NzraPK3iAygB0C-d0oR7BFCsNoXrvaFq33hitaKqlx4JokXJONmPed2cl43_I_6B3UVs0c
CitedBy_id crossref_primary_10_3389_fphar_2021_691019
crossref_primary_10_1002_mnfr_202300867
crossref_primary_10_4196_kjpp_2024_28_2_107
crossref_primary_10_1021_acsnano_4c06369
crossref_primary_10_2174_1389201023666220818145350
Cites_doi 10.1016/0005-2760(94)00247-V
10.1016/j.taap.2013.12.007
10.4049/jimmunol.0801804
10.1074/jbc.M105805200
10.1016/j.chemphyslip.2011.06.006
10.1093/rheumatology/keq007
10.1172/JCI35288
10.3892/ijmm.2019.4135
10.1021/jm901797p
10.4049/jimmunol.0902399
10.1371/journal.pntd.0000886
10.1002/biof.1243
10.1016/j.bbrc.2013.11.052
10.1016/j.bbrc.2013.07.046
10.1016/S0021-9150(98)00196-8
10.1016/j.bbrc.2012.12.021
10.1152/physrev.2000.80.1.361
10.3892/mmr.2017.6491
10.1016/j.cell.2004.09.032
10.1210/me.2013-1051
10.4196/kjpp.2014.18.6.475
10.1046/j.1523-1747.2003.12033.x
10.1016/j.cell.2006.06.049
10.1016/j.bbadis.2014.12.003
10.1080/10715760100300571
10.1016/S0014-5793(02)03578-0
10.1194/jlr.M010686
10.1038/nm820
10.1101/gad.9.9.1033
ContentType Journal Article
Copyright Copyright © Korean J Physiol Pharmacol 2021
Copyright_xml – notice: Copyright © Korean J Physiol Pharmacol 2021
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4196/kjpp.2021.25.2.111
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2093-3827
EndPage 118
ExternalDocumentID oai_kci_go_kr_ARTI_9753312
PMC7893494
33602881
10_4196_kjpp_2021_25_2_111
Genre Journal Article
GroupedDBID ---
5-W
5GY
8JR
8XY
9ZL
AAYXX
ABDBF
ACUHS
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
ESX
F5P
GX1
HYE
MK0
OK1
P2P
P5Y
P6G
RPM
TR2
TUS
.UV
NPM
7X8
5PM
53G
ACYCR
KVFHK
ID FETCH-LOGICAL-c436t-48b4960236f7249d403839aeaee46265f90dbeffe723b44ec17a6b715bfa0ae43
ISSN 1226-4512
IngestDate Sun Mar 09 07:50:49 EDT 2025
Thu Aug 21 18:12:02 EDT 2025
Fri Jul 11 03:45:52 EDT 2025
Thu Jan 02 22:58:04 EST 2025
Tue Jul 01 02:33:17 EDT 2025
Thu Apr 24 23:03:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords 27-Hydroxycholesterol
Liver X receptors
Gene expression
Macrophage
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c436t-48b4960236f7249d403839aeaee46265f90dbeffe723b44ec17a6b715bfa0ae43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7893494
PMID 33602881
PQID 2491940593
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9753312
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7893494
proquest_miscellaneous_2491940593
pubmed_primary_33602881
crossref_primary_10_4196_kjpp_2021_25_2_111
crossref_citationtrail_10_4196_kjpp_2021_25_2_111
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-01
2021-Mar-01
20210301
2021-03
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle The Korean journal of physiology & pharmacology
PublicationTitleAlternate Korean J Physiol Pharmacol
PublicationYear 2021
Publisher The Korean Physiological Society and The Korean Society of Pharmacology
대한약리학회
Publisher_xml – name: The Korean Physiological Society and The Korean Society of Pharmacology
– name: 대한약리학회
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref4
  doi: 10.1016/0005-2760(94)00247-V
– ident: ref11
  doi: 10.1016/j.taap.2013.12.007
– ident: ref21
  doi: 10.4049/jimmunol.0801804
– ident: ref12
  doi: 10.1074/jbc.M105805200
– ident: ref3
  doi: 10.1016/j.chemphyslip.2011.06.006
– ident: ref22
  doi: 10.1093/rheumatology/keq007
– ident: ref25
  doi: 10.1172/JCI35288
– ident: ref8
  doi: 10.3892/ijmm.2019.4135
– ident: ref16
  doi: 10.1021/jm901797p
– ident: ref27
  doi: 10.4049/jimmunol.0902399
– ident: ref24
  doi: 10.1371/journal.pntd.0000886
– ident: ref29
  doi: 10.1002/biof.1243
– ident: ref7
  doi: 10.1016/j.bbrc.2013.11.052
– ident: ref9
  doi: 10.1016/j.bbrc.2013.07.046
– ident: ref2
  doi: 10.1016/S0021-9150(98)00196-8
– ident: ref17
  doi: 10.1016/j.bbrc.2012.12.021
– ident: ref1
  doi: 10.1152/physrev.2000.80.1.361
– ident: ref28
  doi: 10.3892/mmr.2017.6491
– ident: ref26
  doi: 10.1016/j.cell.2004.09.032
– ident: ref14
  doi: 10.1210/me.2013-1051
– ident: ref6
  doi: 10.4196/kjpp.2014.18.6.475
– ident: ref20
  doi: 10.1046/j.1523-1747.2003.12033.x
– ident: ref13
  doi: 10.1016/j.cell.2006.06.049
– ident: ref10
  doi: 10.1016/j.bbadis.2014.12.003
– ident: ref5
  doi: 10.1080/10715760100300571
– ident: ref23
  doi: 10.1016/S0014-5793(02)03578-0
– ident: ref18
  doi: 10.1194/jlr.M010686
– ident: ref19
  doi: 10.1038/nm820
– ident: ref15
  doi: 10.1101/gad.9.9.1033
SSID ssib008505809
ssj0064464
Score 2.2378082
Snippet 27-Hydroxycholesterol (27OHChol) exhibits agonistic activity for liver X receptors (LXRs). To determine roles of the LXR agonistic activity in macrophage gene...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 111
SubjectTerms Original
약리학
Title 27-Hydroxycholesterol induces macrophage gene expression via LXR-dependent and -independent mechanisms
URI https://www.ncbi.nlm.nih.gov/pubmed/33602881
https://www.proquest.com/docview/2491940593
https://pubmed.ncbi.nlm.nih.gov/PMC7893494
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002689670
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX The Korean Journal of Physiology & Pharmacology, 2021, 25(2), , pp.111-118
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2eeEFAeNSbjII8zKlJLZz8WPadYyrENqkvkVx4rCuLJ26Fmn8es5x0iQdBQ1eotY-viTn68k57vFnQl5pJYJAhb6Tac0dmUPMqpUWjpfxyMuULrSl2Pj0OTg6ke_H_nhre7eTtbRc6H72c-O-kv_RKpSBXnGX7D9otukUCuAz6BeuoGG43kjHPHSOrnJMREEjZjkPZsihkS8xz-o8xeO5TjEpB3owSOZfJb2W-z8m6f7H8VdndQRulWbuTMq24NzgnuDJZc1mftai6sNsvlq-r11ZuzxSkTkhki5aOuxmwZ6NYjZQmFcxGrCBYAPJRkOmIhZ5rciQRQFTrq2JWazY6IApH2S7IrHHBq6twcbYnRoxFXVF1IHtf8CiQ6aUbQQus9td4eCdFC-LSSs-tBO0g6qh7QlGP8CqOGDxcFVVTSwG-Y5NBw_TkX6drW1sGXeVcERU0RLUtntl9U39Ldr0hpFgsQAW07MLJDvlXp_7fd5vmnbpvK-9ZtcIvafZJPk2S6bzBMKWdwnubhZ4VvYuD0ObbfB23JrdCLxUy7JWORjgwVpWtOa-qr1gOLM3v89rzd_aLufFplDqekZwx8U6vkNu17ERjSug3yVbprxH9uIyXczOr-hr-qWB2R4pNmKf1tinLfYpYp-22KeAfbqGfQrYp13s0xb798nJ4eh4eOTUZ4Y4mRTBwpGRlhCUcxEUIZcql66AECA1qTESYne_UG6uMVUq5EJLaTIvTAOwR74uUjc1UjwgO-WsNI8INX4hIXpSnKe-zJWrfVVAPOXpQuTgJJse8VZPNslqQn081-V7AoE1aiNBbSSojYT7Ccdgu0f2mzYXFZ3MX6VfgsIsWP4Mmh55sdJnAq8G_L8vLc1seZnA_XtK4pmdPfKw0m8zqBDwkKIIhgjXNN8I4IDrNeXk1NLPhxDiSCUf32RyT8it9hf9lOws5kvzDLz4hX5uMf4L-gnf-Q
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=27-Hydroxycholesterol+induces+macrophage+gene+expression+via+LXR-dependent+and+-independent+mechanisms&rft.jtitle=The+Korean+journal+of+physiology+%26+pharmacology&rft.au=%EA%B9%80%EB%B3%B4%EC%98%81&rft.au=%EC%86%90%EC%9A%A9%ED%95%B4&rft.au=%EC%A1%B0%ED%98%81%EB%9E%98&rft.au=%EC%9D%B4%EB%8F%99%EC%A4%80&rft.date=2021-03-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%BD%EB%A6%AC%ED%95%99%ED%9A%8C&rft.issn=1226-4512&rft.eissn=2093-3827&rft.spage=111&rft.epage=118&rft_id=info:doi/10.4196%2Fkjpp.2021.25.2.111&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9753312
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1226-4512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1226-4512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1226-4512&client=summon